Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1728328 · MTRI, INM

InMed Pharmaceuticals Inc.

Filing with the SEC SEC-reporting company Vancouver, PA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Sep 18, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • RestructuringOn Mar 6, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).
  • Change in controlOn Nov 10, 2026 the company reported a change in control (Item 5.01).
  • Net loss in 2025Net loss of $1.7M for the year (2024: −$7.7M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$4.9M$4.6M
Net income (loss)−$1.7M−$7.7M
Total assets$11.2M$8.5M
Total liabilities$1.6M$2.3M
Stockholders’ equity$9.6M$6.2M
Cash and equivalents$7M$3.4M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends June 30. Check the annual report for the exact figures and periods.

Name as filed
InMed Pharmaceuticals Inc.
CIK
0001728328
Tickers
MTRI, INM
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
British Columbia, Canada
Business address
Vancouver, Pennsylvania
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
June 30
Last annual report
10-K for the period ended Jun 30, 2026
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Appointment of director or officer: Director appointment
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Change in control
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Results announced
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 9.01 · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 3, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 8.01, 9.01 · filed Sep 18, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2026
    Form 10-K · filed Sep 9, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jun 10, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.01, 5.02, 7.01, 9.01 · filed May 19, 2026 · filing
  • Change in control
    Form 8-K · items 1.01, 5.01, 5.02, 7.01, 9.01 · filed May 19, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 6, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 9.01 · filed Mar 30, 2026 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 7.01, 9.01 · filed Mar 6, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2025
    Form 10-Q · filed Feb 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 16, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Oct 14, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2025
    Form 10-K · filed Sep 23, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 9, 2025 · filing
  • Change of auditor
    Form 8-K · items 1.01, 4.01, 5.07, 9.01 · filed Jun 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Feb 14, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2024
    Form 10-Q · filed Feb 12, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Dec 23, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 7.01, 9.01 · filed Nov 5, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2024
    Form 10-K · filed Sep 30, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 7.01, 9.01 · filed Sep 20, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 14, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 7.01, 9.01 · filed Mar 20, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2023
    Form 10-Q · filed Feb 13, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Feb 9, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Nov 8, 2023 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Sep 29, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Jun 30, 2023
    Form 10-K · filed Sep 29, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 25, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Dec 31, 2022
    Form 10-Q · filed Feb 17, 2023 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Feb 10, 2023 · filing